TREVISAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 4.553
EU - Europa 2.574
AS - Asia 2.008
SA - Sud America 125
AF - Africa 23
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.296
Nazione #
US - Stati Uniti d'America 4.490
SG - Singapore 898
HK - Hong Kong 597
IT - Italia 570
IE - Irlanda 487
RU - Federazione Russa 439
DE - Germania 357
SE - Svezia 339
CN - Cina 247
BR - Brasile 103
ID - Indonesia 95
GB - Regno Unito 85
CA - Canada 52
IN - India 47
NL - Olanda 47
UA - Ucraina 46
FI - Finlandia 29
DK - Danimarca 28
VN - Vietnam 28
AT - Austria 26
BE - Belgio 23
ES - Italia 15
TR - Turchia 15
CZ - Repubblica Ceca 14
FR - Francia 13
JP - Giappone 13
AR - Argentina 10
KR - Corea 8
PH - Filippine 8
AU - Australia 7
CH - Svizzera 7
MA - Marocco 7
MX - Messico 7
PL - Polonia 7
SA - Arabia Saudita 7
TH - Thailandia 7
EE - Estonia 6
IR - Iran 6
PK - Pakistan 6
BG - Bulgaria 5
GR - Grecia 5
TN - Tunisia 5
TW - Taiwan 5
HR - Croazia 4
IQ - Iraq 4
LT - Lituania 4
MY - Malesia 4
NO - Norvegia 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
CO - Colombia 3
EG - Egitto 3
EU - Europa 3
KE - Kenya 3
PE - Perù 3
DO - Repubblica Dominicana 2
EC - Ecuador 2
ER - Eritrea 2
IL - Israele 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 9.296
Città #
Ann Arbor 669
Hong Kong 591
Singapore 552
Dublin 474
Chandler 403
Fairfield 387
Ashburn 295
Frankfurt am Main 248
New York 238
Princeton 223
Houston 179
Woodbridge 175
Wilmington 168
Santa Clara 167
Seattle 156
Cambridge 119
Lawrence 107
Milan 101
Altamura 99
Jakarta 93
Shanghai 46
Nuremberg 45
San Diego 44
Toronto 41
Jacksonville 37
Beijing 36
Los Angeles 32
Rome 32
London 25
Andover 24
Brussels 22
Helsinki 20
Dearborn 19
Boardman 18
Nanjing 18
Chicago 15
Bergamo 14
Guangzhou 14
São Paulo 14
Council Bluffs 13
Falls Church 13
Vienna 13
Washington 11
Brno 10
Fuzhou 10
Pune 10
Hangzhou 9
Shenzhen 9
Dong Ket 8
Florence 8
Munich 8
Brescia 7
Madrid 7
Norwalk 7
Redmond 7
Amsterdam 6
Bari 6
Cascina 6
Changsha 6
Chengdu 6
Groningen 6
Kilburn 6
San Mateo 6
Tallinn 6
Tokyo 6
Villafranca Padovana 6
Belo Horizonte 5
Bologna 5
Hyderabad 5
Lappeenranta 5
Mumbai 5
Naples 5
Palermo 5
Riyadh 5
Silver Spring 5
Stockholm 5
Wuhan 5
Zhengzhou 5
Belvedere Spinello 4
Bratislava 4
Canegrate 4
Chennai 4
Deyang 4
Fremont 4
Genoa 4
Hebei 4
Islington 4
Lachine 4
Mexico City 4
Montecchio Maggiore 4
Moscow 4
Oujda 4
Perugia 4
Poznan 4
Rio de Janeiro 4
Turin 4
Verano Brianza 4
Zagreb 4
Bangalore 3
Bengaluru 3
Totale 6.322
Nome #
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched Italian multicenter study. 280
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 253
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 183
Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes 180
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 161
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 155
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 149
Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study 136
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study 126
Continuous subcutaneous insulin infusion in Italy: Third national survey 125
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 125
Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies 123
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 122
Pre-gestational diabetes during the COVID-19 pandemic in Bergamo, Italy 120
Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors 120
Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment 118
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 115
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial 111
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 108
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 103
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes 100
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study 98
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 98
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study 97
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 95
La malattia renale e le sue complicanze: percorso per una diagnosi precoce e gestione multidisciplinare 93
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 92
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study 90
Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: Findings from an administrative database 89
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial 88
Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus 86
The Hyperfiltering Kidney in Diabetes 86
Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: Dalla terapia antitrombotica al trattamento dell'iperglicemia 82
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 82
Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation 80
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial 80
Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy 79
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 79
Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study 78
Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 78
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial 78
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 76
Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 74
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study 74
Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 73
"Insulin autoimmune syndrome": Two very different cases [“Insulin autoimmune syndrome”: Due casi molto diversi] 70
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial 69
Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience 68
Dapagliflozin and cardiovascular outcomes in type 2 diabetes 66
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial 66
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial 65
COMBINED "EN BLOC" LIVER-PANCREAS TRANSPLANTATION USING WHOLE SIZE AND SPLIT LIVER GRAFTS 65
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 65
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy 64
Lipids and renal disease 64
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus 62
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 62
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 61
Impact of a complement factor H gene variant on renal dysfunction, cardiovascular events and response to ACE inhibitor therapy in type 2 diabetes 61
Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population 61
The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction 60
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 59
Diabetes mellitus in critical jobs [Diabete mellito in attività lavorative critiche] 58
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012 58
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 58
Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 58
In situ Protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 57
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial 57
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study 56
Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics 56
Effect of insulin and angiotensin II on cell calcium in human skin fibroblasts 56
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group 56
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial 56
Sodium-hydrogen antiporter: Its possible role in the genesis of diabetic nephropathy 55
Treatment of diabetes in patients with kidney disease 55
Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control 55
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 54
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes 54
Ronal and metabolic effects of insulin lispro in type 2 diabetic sublects with overt nephropathy 54
Modulatory effect of insulin on release of calcium from human fibroblasts by angiotensin II 54
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes 53
Diabetes and work: The need of a close collaboration between diabetologist and occupational physician 53
A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria 52
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial 52
Resilience in pregnant women with pre-gestational diabetes during COVID-19 pandemic: the experience of the Papa Giovanni XXIII Hospital in Bergamo, Italy 52
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria 52
Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus 50
Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes 50
The effect of Mindfulness therapy in acromegaly, a pilot study 49
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control 49
The decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes 49
PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates 49
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial 49
Preventing microalbuminuria in type 2 diabetes 48
Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme 48
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial) 48
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 47
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus 46
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin 45
Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems 45
Totale 8.119
Categoria #
all - tutte 58.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.353


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020106 0 0 0 0 0 0 0 0 0 51 35 20
2020/20211.525 176 174 157 119 74 85 150 123 110 154 94 109
2021/20221.202 99 85 90 67 23 42 60 58 41 256 73 308
2022/20231.926 217 589 154 104 165 327 5 84 114 45 64 58
2023/20241.789 53 48 63 68 264 416 302 61 252 43 22 197
2024/20252.909 249 483 171 193 449 222 198 136 745 63 0 0
Totale 9.927